Changes in antigen-specific T-cell number and function during oral desensitization in cow's milk allergy enabled with omalizumab. - Wikidata - awgldk - TriplyDB

Changes in antigen-specific T-cell number and function during oral desensitization in cow's milk allergy enabled with omalizumab.

Changes in antigen-specific T-cell number and function during oral desensitization in cow's milk allergy enabled with omalizumab.

http://www.wikidata.org/entity/Q35894673

about

Oral immunotherapy for milk allergy In utero arsenic exposure and fetal immune repertoire in a US pregnancy cohort Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3).Food allergy diagnosis and therapy: where are we now?Oral and sublingual immunotherapy.Peyer's patches and mesenteric lymph nodes cooperatively promote enteropathy in a mouse model of food allergy.Oral and sublingual immunotherapy for food allergy: current progress and future directions.The Potential of Anti-IgE in Food Allergy Therapy.Modulation of dendritic cell innate and adaptive immune functions by oral and sublingual immunotherapy Oral immunotherapy induces IgG antibodies that act through FcγRIIb to suppress IgE-mediated hypersensitivity.A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients.Successful immunotherapy induces previously unidentified allergen-specific CD4+ T-cell subsets.What's new in the diagnosis and management of food allergy in children?An IgE receptor mimetic peptide (PepE) protects mice from IgE mediated anaphylaxis.Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab.Enhanced shedding of extracellular vesicles from amoeboid prostate cancer cells: potential effects on the tumor microenvironment.Use of IgE and IgG4 epitope binding to predict the outcome of oral immunotherapy in cow's milk allergy.Immunological mechanisms for desensitization and tolerance in food allergy.Development of natural tolerance and induced desensitization in cow's milk allergy.Anti-IgE--emerging opportunities for Omalizumab.Heated allergens and induction of tolerance in food allergic children.The changing geoepidemiology of food allergies.The evolution of allergen and non-specific immunotherapy: past achievements, current applications and future outlook.The future of biologics: applications for food allergy.EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders.An Examination of Clinical and Immunologic Outcomes in Food Allergen Immunotherapy by Route of Administration.IgE receptor signaling in food allergy pathogenesis.Markers of tolerance development to food allergens.Human Immune Monitoring Techniques during Food Allergen Immunotherapy.Mechanistic correlates of clinical responses to omalizumab in the setting of oral immunotherapy for milk allergy.Immunologic effects of omalizumab in children with severe refractory atopic dermatitis: a randomized, placebo-controlled clinical trial.Oral Food Desensitization in Children With IgE-Mediated Cow's Milk Allergy: Immunological Changes Underlying Desensitization.Conference Scene: novelties in immunotherapy.Low-Dose Allergen-Specific Immunotherapy Induces Tolerance in a Murine Model of Shrimp Allergy.Allergen-Specific T Cells in IgE-Mediated Food Allergy.Antigen-specific Treg cells in immunological tolerance: implications for allergic diseases.Allergen-specific IgG antibody signaling through FcγRIIb promotes food tolerance.Omalizumab facilitates rapid oral desensitization for peanut allergy.Mechanisms of Oral Tolerance.Oral Immunotherapy With Omalizumab Reverses the Th2 Cell-Like Program of Regulatory T cells and Restores their Function.

P2860

Q24202867-3D5A9DC5-EE3A-4A5B-A4B8-08EFA51AD822 Q28386872-5D8995F1-7C45-4BF6-9438-E8DCC7542C02 Q33999649-163D67AA-07C8-4AC6-B549-C2B3AF424DE8 Q34000536-4135906A-E59E-4083-AE16-939C14987C01 Q34044108-47B3FF72-D442-476A-B518-DF86F9DB86F5 Q34301480-C7D7F954-C7B5-4973-ADA6-C4BF288E0947 Q34366285-DA7D9543-5AAC-4B0F-83B8-B3A0E7EA9447 Q34532292-9C5088B0-7351-4C2E-8CC8-407145B1E604 Q34613611-18D82231-EA71-46FC-90C5-A016717371D9 Q34664144-57D1A027-41BC-4EDF-B135-F06A435096A5 Q35510416-A3F36B43-7172-43CC-91B1-58365495447E Q36658984-62DBCD6A-5C40-4022-95C0-609C53E555BA Q36813250-F3600118-C5A0-41E6-BCEA-2BF650EE32B5 Q37288228-9AFDA5A1-B535-4A8E-99BC-DAC545822F39 Q37607069-F1684A5F-068F-43BB-9E34-D8828E6FA528 Q37692454-97D4B763-BF93-40C7-A55A-C37004B85C1E Q37719803-6568102A-35BB-4FAE-AE36-9749A78EA14B Q38028369-7430F3EE-F2C8-4AF1-AD19-9F28231CFB4B Q38041573-17D5E296-FF97-4AF6-8120-6BC92BEA2E69 Q38091754-01B9A955-1D2C-4E92-AEBE-19E5F8D84FEF Q38112250-9747ECBF-3F37-4DF8-9A19-E6569F4ED948 Q38188844-C94D13B8-02FD-41EF-A91D-61BD76B32495 Q38278145-1B1C99F4-D190-41AF-8F33-61CE2BFF6F7B Q38348057-4F33E9EE-160A-4A02-89FA-A4300B0D9F19 Q38394577-DF56C539-564C-4DF0-AF59-7264CD517590 Q38542587-D1C6544C-C937-4103-A451-CB0B17702BD5 Q38571093-E881669A-F37F-408E-A58A-F93458FE1FFB Q38861295-C1F136A3-0A48-48EE-B583-3038B204E15A Q39210376-12941BCB-8A65-4176-A203-E6D3CE43D1A8 Q40249043-D6EB90F7-C42F-488C-8622-3298A3CE7108 Q42139482-86F3FC00-ADA3-4E0F-A6D2-604FEC765098 Q42371153-A1B0559F-6A2A-499C-A8B0-7081506EF844 Q45160730-12E2CDA0-DE67-4C54-B6FD-790007F7C2C3 Q47609875-46325A4E-4557-43C3-9F1D-59EFE9FF836A Q47801866-090BA20B-1027-4C99-9C06-B972B4804A3E Q48155143-4AA21FB0-C586-47D9-8099-91F19F726DC1 Q51016355-E19D55A4-1381-4C62-A430-304DF3D97524 Q51526766-4ED50DA7-C447-4FCD-B730-EFDBE94076BA Q52682112-7DDFCFD2-FBB5-4DF7-BD35-A6B93EA17177 Q52716354-46909832-3A76-40F2-B244-912B23CF2309

P2860

Changes in antigen-specific T-cell number and function during oral desensitization in cow's milk allergy enabled with omalizumab.

http://www.wikidata.org/entity/Q35894673

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Changes in antigen-specific T- ...... lergy enabled with omalizumab.

@ast

Changes in antigen-specific T- ...... lergy enabled with omalizumab.

@en

type

label

Changes in antigen-specific T- ...... lergy enabled with omalizumab.

@ast

Changes in antigen-specific T- ...... lergy enabled with omalizumab.

@en

prefLabel

Changes in antigen-specific T- ...... lergy enabled with omalizumab.

@ast

Changes in antigen-specific T- ...... lergy enabled with omalizumab.

@en

P1433

Q35894673-BF5FBBE9-4580-4CD4-B41D-346C5EAA7A35

P1476

Q35894673-5A7781DC-8F4C-4E57-B6B6-10D575C03A1E

P2093

Q35894673-571A5084-467E-44BD-96B8-6E006C0ACF02

Q35894673-7657152A-1C2D-406F-9299-0B293980D879

Q35894673-7A477E48-2F9A-42BA-930D-FDF70D1AC870

Q35894673-7EF33365-4E3D-4153-8490-14682322A33B

Q35894673-910B9200-4183-4063-AC60-B35340742336

Q35894673-BE3E9E7A-11A1-49D3-A3AC-D39B75151805

Q35894673-C146FCC0-B310-48A2-81A3-70529322981B

Q35894673-C23C54BB-B8DF-4793-8B21-986965067EF0

Q35894673-D4239C14-770E-4A00-86BC-875CB822B14A

P2860

Q35894673-0542A6B2-BEEC-48CB-BE98-BC785A149360

Q35894673-1012FC83-1379-4A77-BB7C-38B268DB564F

Q35894673-15E85527-92E2-4F3A-B898-51D1F9FCF79B

Q35894673-196ED5FC-DBA1-4C38-8747-A99643D23640

Q35894673-3B3C005A-C376-4207-B433-C46C9A675B19

Q35894673-57DA4ABA-CC0B-409D-ACED-082343874721

Q35894673-58D1C055-E489-4445-933A-169615E9F802

Q35894673-5BBECC44-5A27-4261-B2FA-52E3DF895796

Q35894673-6FDC1E9B-BEE1-4558-A8A1-5B9226243FFD

Q35894673-6FFE00D8-0B6B-4487-8E81-BFAED978B684

P2888

Q35894673-4671017F-A1CB-472A-864B-3108C62AFFFB

P304

Q35894673-E87E96B6-3106-4712-B437-BBB33AE4FA84

P31

Q35894673-0736543E-1412-4661-A0DB-130F78767C12

P356

Q35894673-D215B311-AB0E-45BF-870B-5929E5EBE3D7

P433

Q35894673-3A0A1E46-2F38-4729-A697-94F025180400

P478

Q35894673-4B55FD92-0BDD-443C-B35F-445A466DD815

P577

Q35894673-9899206C-FE0D-48DD-A502-B60BD49A0FB3

P5875

Q35894673-9BBCF957-9EB2-4692-9387-3096B7E2E436

P698

Q35894673-E1C88D9B-EFF0-4410-BB84-DD0C78BC2BF7

P932

Q35894673-3B601BEB-9BA2-46FC-847F-6D0E1D456B39

P356

P1433

Mucosal Immunology

P1476

Changes in antigen-specific T- ...... lergy enabled with omalizumab.

@en

P2093

A K Singh

http://www.w3.org/2001/XMLSchema#string

D Bedoret

http://www.w3.org/2001/XMLSchema#string

D T Umetsu

http://www.w3.org/2001/XMLSchema#string

E G Hoyte

http://www.w3.org/2001/XMLSchema#string

K C Nadeau

http://www.w3.org/2001/XMLSchema#string

L C Schneider

http://www.w3.org/2001/XMLSchema#string

R H DeKruyff

http://www.w3.org/2001/XMLSchema#string

R Hamilton

http://www.w3.org/2001/XMLSchema#string

V Shaw

http://www.w3.org/2001/XMLSchema#string

P2860

Tracking antigen-specific T-cells during clinical tolerance induction in humans

T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity

Immunological mechanisms of allergen-specific immunotherapy

FOXP3+ regulatory T cells in the human immune system

Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.

9. Food allergy.

CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid.

Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report

The natural history of IgE-mediated cow's milk allergy.

Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein.

P2888

P304

267-276

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MI.2012.5

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221817436

http://www.w3.org/2001/XMLSchema#string

P698

22318492

http://www.w3.org/2001/XMLSchema#string

P932

3328586

http://www.w3.org/2001/XMLSchema#string